209 related articles for article (PubMed ID: 31885887)
1. Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy.
Someya H; Takayama K; Takeuchi M; Yokoyama H; Kimura T; Morioka M; Takamura Y; Sameshima S; Ueda T; Ogata N; Tashiro M; Kitano S; Sakamoto T
J Ophthalmol; 2019; 2019():5304524. PubMed ID: 31885887
[TBL] [Abstract][Full Text] [Related]
2. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
Naser H; Koss MJ; Singh P; Koch F
Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
[TBL] [Abstract][Full Text] [Related]
3. Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.
Kim KT; Jang JW; Kang SW; Chae JB; Cho K; Bae K
Korean J Ophthalmol; 2019 Jun; 33(3):249-258. PubMed ID: 31179656
[TBL] [Abstract][Full Text] [Related]
4. Diode laser, vitrectomy and intravitreal triamcinolone. A comparative study for the treatment of diffuse non tractional diabetic macular edema.
Parolini B; Panozzo G; Gusson E; Pinackatt S; Bertoldo G; Rottini S; Pignatto S
Semin Ophthalmol; 2004; 19(1-2):1-12. PubMed ID: 15658006
[TBL] [Abstract][Full Text] [Related]
5. ILM peeling in nontractional diabetic macular edema: review and metanalysis.
Rinaldi M; dell'Omo R; Morescalchi F; Semeraro F; Gambicorti E; Cacciatore F; Chiosi F; Costagliola C
Int Ophthalmol; 2018 Dec; 38(6):2709-2714. PubMed ID: 29090356
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
7. VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study.
Bonnin S; Sandali O; Bonnel S; Monin C; El Sanharawi M
Retina; 2015 May; 35(5):921-8. PubMed ID: 25545486
[TBL] [Abstract][Full Text] [Related]
8. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
Figueroa MS; Contreras I; Noval S
Retina; 2008 Mar; 28(3):420-6. PubMed ID: 18327133
[TBL] [Abstract][Full Text] [Related]
9. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
[TBL] [Abstract][Full Text] [Related]
10. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
[TBL] [Abstract][Full Text] [Related]
11. Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema.
Ulrich JN
Open Ophthalmol J; 2017; 11():5-10. PubMed ID: 28567164
[TBL] [Abstract][Full Text] [Related]
12. Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.
Lee Y; Kang S; Park YH
Korean J Ophthalmol; 2013 Feb; 27(1):28-33. PubMed ID: 23372376
[TBL] [Abstract][Full Text] [Related]
13. Is immediate treatment necessary for diabetic macular edema after pars plana vitrectomy for tractional complications of proliferative diabetic retinopathy?
Behera UC; Das T; Sivaprasad S; Rani PK; Raman R; Agarwal M; Agarwal T; Sahu S; Vaidya H; Panchal B;
Int Ophthalmol; 2021 Nov; 41(11):3607-3614. PubMed ID: 34170479
[TBL] [Abstract][Full Text] [Related]
14. [One year outcomes of pars plana vitrectomy in proliferative diabetic retinopathy].
Tadera M; Kawamura H; Fujikawa M; Kakinoki M; Sawada T; Saishin Y; Ohji M
Nippon Ganka Gakkai Zasshi; 2014 Jun; 118(6):502-7. PubMed ID: 25016792
[TBL] [Abstract][Full Text] [Related]
15. [Pars plana vitrectomy and combination therapy pars plana vitrectomy, intravitreal triamcinolon acetonid and macular lasercoagulation - one year results].
Stefaničková J; Strmeň P; Vavrová K; Mrózová L; Krásnik V
Cesk Slov Oftalmol; 2012 Nov; 68(5):180-8. PubMed ID: 23461369
[TBL] [Abstract][Full Text] [Related]
16. Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema.
Ranno S; Vujosevic S; Mambretti M; Metrangolo C; Alkabes M; Rabbiolo G; Govetto A; Carini E; Nucci P; Radice P
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983298
[TBL] [Abstract][Full Text] [Related]
17. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of vitrectomy, membranectomy and internal limiting membrane peeling in patients with refractory diabetic macular edema and non-tractional epiretinal membrane.
Ghassemi F; Bazvand F; Roohipoor R; Yaseri M; Hassanpoor N; Zarei M
J Curr Ophthalmol; 2016 Dec; 28(4):199-205. PubMed ID: 27830204
[TBL] [Abstract][Full Text] [Related]
19. Pars plana vitrectomy for tractional diabetic macular edema with or without internal limiting membrane peeling.
Khattab AAA; Ahmed MM; Hammed AH
Med Hypothesis Discov Innov Ophthalmol; 2022; 11(3):110-118. PubMed ID: 37641643
[TBL] [Abstract][Full Text] [Related]
20. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
Hartley KL; Smiddy WE; Flynn HW; Murray TG
Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
